STOCK TITAN

E-BUY HOME INC - $EBYH STOCK NEWS

Welcome to our dedicated page for E-BUY HOME news (Ticker: $EBYH), a resource for investors and traders seeking the latest updates and insights on E-BUY HOME stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect E-BUY HOME's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of E-BUY HOME's position in the market.

Rhea-AI Summary
Strainsforpains, Inc. (EBYH) announces a strategic partnership with GenBio to license new anti-inflammatory compounds for CBD products. GenBio aims to develop potent anti-inflammatory drugs with lower toxicity. The partnership targets the health and wellness market, focusing on natural extracts from Australia. GenBio plans to enter an Investigational New Drug program in the US. Strainsforpains anticipates a positive impact on sales and operations in the next quarters.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary
Strainsforpains, Inc. (EBYH) announces a $130,000 distribution order from Exploration Solutions, LLC for CBD body cream, aiming to exceed $500,000 in sales for 2024. The company plans to expand its product line, engage in partnerships, and launch a proprietary app with advanced AI for pain management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.09%
Tags
none
-
Rhea-AI Summary
StrainsForPains, Inc. (EBYH) introduces a medical marijuana recommendation engine to assist patients in finding the right cannabinoid levels, cannabis strains, and consumption methods for their ailments. CEO Simon Shainberg discusses the company's innovative approach on Stock Day Podcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Strainsforpains, Inc. (EBYH) increases capacity for CBD product line, projects sales over $500,000 for fiscal 2024. Renewing Cannasphere JV agreement for research on glaucoma and gastrointestinal issues. Focus on innovation and growth with water-soluble CBD products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.55%
Tags
none
-
Rhea-AI Summary
Strainsforpains, Inc. achieved a major milestone by closing out 2023 with its largest orders to date, valued at $65,000, from various CBD and health markets in New York City. The company continues its collaboration with Popped, a NYC company, to jointly develop products and services with anticipated sales of six hundred thousand dollars by the end of 2024. Strainsforpains also plans to diversify its product offerings by introducing water-soluble liposomal technology to increase the absorption of CBD by 80%. The company's data technology division is expected to experience a substantial increase in sales in 2024. With a commitment to innovation, superior quality, and customer satisfaction, Strainsforpains is well-positioned to drive substantial growth in the coming year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
none
-
E-BUY HOME INC

OTC:EBYH

EBYH Rankings

EBYH Stock Data

1.78M
Crude Petroleum and Natural Gas Extraction
Mining, Quarrying, and Oil and Gas Extraction
Link
United States of America
New York